ADORA2B and ovarian carcinoma: We analyzed if the expression level of the ADORA2B transcript (coding for A2BR) correlated with the surveillance probability of ovarian carcinoma patients using the Kaplan–Meier Plotter database (K-MPdb) [25,26].